Chemotherapy-induced peripheral neuropathy: a current review

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,314 · see citing works

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Stewart, A. K., Rajkumar, S. V., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Mihaylov, G. G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411321 · Cited by 1,332 · see citing works

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

Smith, E., Pang, H., Cirrincione, C., Fleishman, S. B., Paskett, E. D., Ahles, T. A., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N. A., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,016 · see citing works

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Moreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Grishunina, M., Rekhtman, G., Masliak, Z., Robak, T., Shubina, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70081-x · Cited by 920 · see citing works

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

Miguel, J. F. S., Weisel, K. C., Moreau, P., Lacy, M. Q., Song, K., Delforge, M., Karlin, L., Goldschmidt, H., Banos, A., Oriol, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70380-2 · Cited by 800 · see citing works

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Richardson, P. G. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J. R., Singhal, S., Siegel, D. S. D., Irwin, D. H., Schuster, M. K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 644 · see citing works

Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors

Chambers, S. M., Qi, Y., Mica, Y., Lee, G., Zhang, X., Niu, L., Bilsland, J., Cao, L., Stevens, E. B., Whiting, P. J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2249 · Cited by 605 · see citing works

Pluripotent stem cells in disease modelling and drug discovery

Avior, Y., Sagi, I., & Benvenisty, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.27 · Cited by 592 · see citing works

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

Zimmer, L., Goldinger, S. M., Hofmann, L., Loquai, C., Ugurel, S., Thomas, I., Schmidgen, M. I., Gutzmer, R., Utikal, J. S., Göppner, D., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.02.024 · Cited by 564 · see citing works

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Voskens, C., Goldinger, S. M., Loquai, C., Robert, C., Kaehler, K. C., Berking, C., Bergmann, T., Bockmeyer, C. L., Eigentler, T., Fluck, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053745 · Cited by 463 · see citing works

Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report

Grisariu, S., Avni, B. R., Batchelor, T. T., et al. (2010) · Blood · doi:10.1182/blood-2009-12-258210 · Cited by 345 · see citing works

Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons

Podratz, J. L., Knight, A. M., Ta, L. E., Staff, N. P., Gass, J. M., Genelin, K., Schlattau, A., Lathroum, L., & Windebank, A. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.017 · Cited by 322 · see citing works

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, D. R., Qin, R., Seisler, D. K., Smith, E., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner‐Johnston, N. D., Ruddy, K. J., Dakhil, S. R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8533 · Cited by 312 · see citing works

Interventions for preventing neuropathy caused by cisplatin and related compounds

Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 302 · see citing works

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

Loprinzi, C. L., Reeves, B., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A. H., Le-Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0308 · Cited by 282 · see citing works

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

Diouf, B., Crews, K. R., Lew, G., et al. (2015) · JAMA · doi:10.1001/jama.2015.0894 · Cited by 281 · see citing works

Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.

Gill, J. S., & Windebank, A. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1130 · Cited by 279 · see citing works

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer

Frisina, R. D., Wheeler, H. E., Fosså, S. D., Kerns, S. L., Fung, C., Sesso, H. D., Monahan, P. O., Feldman, D. R., Hamilton, R. J., Vaughn, D. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8822 · Cited by 278 · see citing works

Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice

Geisler, S., Doan, R. A., Strickland, A. M., Huang, X., Milbrandt, J., & DiAntonio, A. (2016) · Brain · doi:10.1093/brain/aww251 · Cited by 272 · see citing works

Evaluation of long-term toxicity after chemotherapy for testicular cancer.

Bokemeyer, C., Berger, C. C., Kuczyk, M., & Schmoll, H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.2923 · Cited by 266 · see citing works

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71125-8 · Cited by 262 · see citing works

Neurolymphomatosis

Baehring, J. M. (2003) · Neuro-Oncology · doi:10.1215/15228517-5-2-104 · Cited by 253 · see citing works

Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment

Gertz, M. A. (2014) · American Journal of Hematology · doi:10.1002/ajh.23828 · Cited by 242 · see citing works

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy

Park, S. B., Lin, C. S.-Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2009) · Brain · doi:10.1093/brain/awp219 · Cited by 232 · see citing works

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8566 · Cited by 229 · see citing works

Lymphoma and peripheral neuropathy: A clinical review

Kelly, J. J., & Karcher, D. S. (2004) · Muscle & Nerve · doi:10.1002/mus.20163 · Cited by 223 · see citing works

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Broyl, A., Corthals, S. L., Jongen, J. L. M., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219 · see citing works

Vincristine Neurotoxicity

ROSENTHAL, S., & KAUFMAN, S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-6-733 · Cited by 217 · see citing works

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

Lecomte, T., Landi, B., Beaune, P. H., Laurent‐Puig, P., & Loriot, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211 · see citing works

Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel

Xiao, W. H., Zheng, H., & Bennett, G. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.023 · Cited by 210 · see citing works

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na V 1.6-resurgent and persistent current

Sittl, R., Lampert, A., Huth, T., Schuy, E. T., Link, A., Fleckenstein, J., Alzheimer, C., Grafe, P., & Carr, R. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118058109 · Cited by 209 · see citing works

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Baldwin, R. M., Owzar, K., Zembutsu, H., Chhibber, A., Kubo, M., Jiang, C., Watson, D. M., Eclov, R. J., Mefford, J., McLeod, H. L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1590 · Cited by 204 · see citing works

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

Pike, C. T., Birnbaum, H. G., Muehlenbein, C. E., et al. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/913848 · Cited by 203 · see citing works

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

Fullerton, P. M., & O'Sullivan, D. J. (1968) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.31.6.543 · Cited by 203 · see citing works

Patterns and severity of vincristine‐induced peripheral neuropathy in children with acute lymphoblastic leukemia

Smith, E., Li, L., Chiang, C., et al. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12114 · Cited by 198 · see citing works

Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy

Zheng, H., Xiao, W. H., & Bennett, G. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.023 · Cited by 186 · see citing works

Clinicopathological features of neuropathy associated with lymphoma

Tomita, M., Koike, H., Kawagashira, Y., Iijima, M., Adachi, H., Taguchi, J., Abe, T., Sako, K., Tsuji, Y., Nakagawa, M., et al. (2013) · Brain · doi:10.1093/brain/awt193 · Cited by 184 · see citing works

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab

Gan, H. K., Azad, A., Cher, L., et al. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop021 · Cited by 177 · see citing works

Toxic neuropathy in patients with pre-existing neuropathy

Chaudhry, V., Chaudhry, M. A., Crawford, T. O., Simmons-OʼBrien, E., & Griffin, J. W. (2003) · Neurology · doi:10.1212/01.wnl.0000043691.53710.53 · Cited by 173 · see citing works

Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy

Chaudhry, V., Cornblath, D. R., Polydefkis, M. J., Ferguson, A. K., & Borrello, I. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00193.x · Cited by 172 · see citing works

Multi‐center assessment of the Total Neuropathy Score for chemotherapy‐induced peripheral neurotoxicity

Cavaletti, G., Jann, S., Pace, A., et al. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00078.x · Cited by 170 · see citing works

Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia

Ramchandren, S., Leonard, M., Mody, R. J., et al. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00230.x · Cited by 163 · see citing works

Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy

Reeves, B., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A. H., Le-Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., Kelaghan, J. W., et al. (2012) · Cancer · doi:10.1002/cncr.27489 · Cited by 161 · see citing works

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation

Gopal, A. K., Ramchandren, R., O’Connor, O. A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-397893 · Cited by 161 · see citing works

Peripheral Neuropathy with Microtubule-Targeting Agents: Occurrence and Management Approach

Carlson, K.-S., & Ocean, A. J. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.03.006 · Cited by 154 · see citing works

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199

Schneider, B. P., Li, L., Radovich, M., Shen, F., Miller, K. D., Flockhart, D. A., Jiang, G., Vance, G. H., Gardner, L., Vatta, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0586 · Cited by 144 · see citing works

Spectrum of paraneoplastic disease associated with lymphoma

Briani, C., Vitaliani, R., Grisold, W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820d62eb · Cited by 138 · see citing works

Amyloid Neuropathies

Shin, S. C., & Robinson‐Papp, J. (2012) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.21352 · Cited by 138 · see citing works

Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors

Bentzen, A. G., Balteskard, L., Wanderås, E. H., Frykholm, G. J., Wilsgaard, T., Dahl, O., & Guren, M. G. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.770599 · Cited by 137 · see citing works

Cisplatin-Induced Apoptosis of DRG Neurons Involves Bax Redistribution and Cytochrome cRelease But Not fas Receptor Signaling

McDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 132 · see citing works

Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain

Nokia, M. S., Anderson, M. L., & Shors, T. J. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12007 · Cited by 131 · see citing works

Diagnosis and Management of Neurolymphomatosis

Baehring, J. M., & Batchelor, T. T. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31826c5ad5 · Cited by 131 · see citing works

Vincristine-Induced Neuropathy as the Initial Presentation of Charcot-Marie-Tooth Disease in Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study

Chauvenet, A. R., Shashi, V., Selsky, C., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200304000-00010 · Cited by 121 · see citing works

Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study

Argyriou, A. A., Cavaletti, G., Antonacopoulou, A. G., et al. (2013) · Cancer · doi:10.1002/cncr.28234 · Cited by 109 · see citing works

Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel

Abraham, J., Guo, Q. J., Dorling, L., Tyrer, J. P., Ingle, S., Hardy, R., Vallier, A.-L., Hiller, L., Burns, R., Jones, L. R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3232 · Cited by 109 · see citing works

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

Majithia, N., Temkin, S. M., Ruddy, K. J., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-3063-4 · Cited by 107 · see citing works

Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons

Staff, N. P., Podratz, J. L., Grassner, L., Lange, M. L. B., Paz, J., Knight, A. M., Loprinzi, C. L., Trushina, E. V., & Windebank, A. J. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.09.001 · Cited by 103 · see citing works

Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma

Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 102 · see citing works

Polyneuropathy complicating bone marrow and solid organ transplantation

Amato, A. A., Barohn, R. J., Sahenk, Z., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1513 · Cited by 101 · see citing works

Vincristine-induced Neuropathy in Childhood ALL (Acute Lymphoblastic Leukemia) Survivors

Jain, P., Gulati, S., Seth, R. K., et al. (2013) · Journal of Child Neurology · doi:10.1177/0883073813491829 · Cited by 98 · see citing works

Immune-mediated neuropathies in myeloma patients treated with bortezomib

Ravaglia, S., Corso, A., Piccolo, G., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.08.007 · Cited by 96 · see citing works

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

de Maleissye, M., Nicolas, G., & Saïag, P. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1515584 · Cited by 94 · see citing works

Therapeutic Angiogenesis Inhibits or Rescues Chemotherapy-induced Peripheral Neuropathy: Taxol- and Thalidomide-induced Injury of Vasa Nervorum is Ameliorated by VEGF

Kirchmair, R., Tietz, A. B., Panagiotou, E. M., Walter, D. H., Silver, M., Yoon, Y., Schratzberger, P., Weber, A. C., KUSANO, K. F., Weinberg, D. H., et al. (2006) · Molecular Therapy · doi:10.1038/sj.mt.6300019 · Cited by 92 · see citing works

Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?

Viala, K., Béhin, A., Maisonobe, T., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.125930 · Cited by 88 · see citing works

Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study

Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 82 · see citing works

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

Leandro-Garcia, L. J., Inglada‐Pérez, L., Pita, G., Hjerpe, E., Leskelä, S., Jara, C., Mielgo-Rubio, X., González‐Neira, A., Robledo, M., Åvall-Lundqvist, E. H., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101466 · Cited by 79 · see citing works

Sequencing of C harcot– M arie– T ooth disease genes in a toxic polyneuropathy

Beutler, A. S., Kulkarni, A. A., Kanwar, R., Klein, C. J., Therneau, T. M., Qin, R., Banck, M. S., Boora, G. K., Ruddy, K. J., Wu, Y., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24265 · Cited by 76 · see citing works

Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy

Meregalli, C., Chiorazzi, A., Carozzi, V., et al. (2013) · Cell Cycle · doi:10.4161/cc.27476 · Cited by 76 · see citing works

Antiangiogenesis Mediates Cisplatin-Induced Peripheral Neuropathy

Kirchmair, R., Walter, D. H., Ii, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.470849 · Cited by 75 · see citing works

Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish

Lisse, T. S., Elias, L. J., Pellegrini, A. D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525096113 · Cited by 74 · see citing works

Scrambler Therapy for the management of chronic pain

Majithia, N., Smith, T. J., Coyne, P. J., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3177-3 · Cited by 74 · see citing works

Bortezomib Induces the Formation of Nuclear poly(A) RNA Granules Enriched in Sam68 and PABPN1 in Sensory Ganglia Neurons

Casafont, Í., Berciano, M. T., & Lafarga, M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9086-1 · Cited by 73 · see citing works

Whole-Exome Sequencing Reveals Defective CYP3A4 Variants Predictive of Paclitaxel Dose-Limiting Neuropathy

Apellániz-Ruiz, M., Lee, M., Sánchez, L. M. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1758 · Cited by 72 · see citing works

Therapy‐related peripheral neuropathy in multiple myeloma patients

Morawska, M., Grząśko, N., Kostyra, M., Wojciechowicz, J., & Hus, M. (2014) · Hematological Oncology · doi:10.1002/hon.2149 · Cited by 71 · see citing works

Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

Leandro-Garcia, L. J., Leskelä, S., Jara, C., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1221 · Cited by 70 · see citing works

Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients

Johnson, C., Pankratz, V. S., Velázquez, A. I., Aakre, J. A., Loprinzi, C. L., Staff, N. P., Windebank, A. J., & Yang, P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.041 · Cited by 68 · see citing works

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study

Custodio, A., Moreno‐Rubio, J., Aparicio, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt546 · Cited by 62 · see citing works

Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population

Gutiérrez-Camino, Á., Martín‐Guerrero, I., López-López, E., et al. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000191 · Cited by 61 · see citing works

Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy

Wheeler, H. E., Gamazon, E. R., Wing, C., Njiaju, U. O., Njoku, C. M., Baldwin, R. M., Owzar, K., Jiang, C., Watson, D. M., Shterev, I. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2618 · Cited by 59 · see citing works

Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings

Brugnoletti, F., Morris, E. B., Laningham, F. H., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21764 · Cited by 55 · see citing works

Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

Boora, G. K., Kulkarni, A. A., Kanwar, R., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.056 · Cited by 51 · see citing works

Block of axoplasmic transport in vitro by vinca alkaloids

Chan, S. Y., Worth, R. M., & Ochs, S. (1980) · Journal of Neurobiology · doi:10.1002/neu.480110304 · Cited by 51 · see citing works

An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India

Schultz, K. R., Ranade, S., Neglia, J. P., & Ravindranath, Y. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1 · Cited by 50 · see citing works

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Krop, I. E., Modi, S., LoRusso, P. M., Pegram, M. D., Guardino, E., Althaus, B., Lu, D., Strasak, A. M., & ELIAS, A. D. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0691-7 · Cited by 49 · see citing works

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)

Binda, D., Vanhoutte, E. K., Cavaletti, G., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.004 · Cited by 48 · see citing works

Vincristine exacerbates asymptomatic Charcot–Marie–Tooth disease with a novel EGR2 mutation

Nakamura, T., Hashiguchi, A., Suzuki, S., et al. (2012) · Neurogenetics · doi:10.1007/s10048-012-0313-1 · Cited by 48 · see citing works

Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran

Shahriari-Ahmadi, A., Fahimi, A., Payandeh, M., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.17.7603 · Cited by 45 · see citing works

Vasculitic neuropathy induced by pembrolizumab

Aya, F., Ruíz-Esquide, V., Viladot, M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw613 · Cited by 42 · see citing works

Proteasome inhibition induces DNA damage and reorganizes nuclear architecture and protein synthesis machinery in sensory ganglion neurons

Palanca, A., Casafont, Í., Berciano, M. T., & Lafarga, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1474-2 · Cited by 39 · see citing works

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology

Chen, E. I., Crew, K. D., Trivedi, M. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145816 · Cited by 39 · see citing works

The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma

Grover, J. K., Uppal, G., & Raina, V. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf258 · Cited by 38 · see citing works

Effects of taxol on slow and fast axonal transport

Komiya, Y., & Tashiro, T. (1988) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970110302 · Cited by 37 · see citing works

Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis

Peng, Z., Wang, Q., Gao, J., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2194-x · Cited by 37 · see citing works

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients

Chen, J., Yin, J., Li, X., Wang, Y., Zheng, Y., Qian, C., Xiao, L., Zou, T., Wang, Z., Liu, J., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121011 · Cited by 37 · see citing works

Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel

Omlin, A. G., Sartor, O. A., Rothermundt, C. A., et al. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.01.010 · Cited by 36 · see citing works

Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)

Chhibber, A., Mefford, J., Stahl, E. A., Pendergrass, S. A., Baldwin, R. M., Owzar, K., Li, M., Winer, E. P., Hudis, C. A., Zembutsu, H., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.2 · Cited by 35 · see citing works

Bortezomib‐induced inflammatory neuropathy

Saifee, T. A., Elliott, K. J., Lunn, M. P., et al. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00287.x · Cited by 35 · see citing works

Neurologic complications of bone marrow transplantation

Krouwer, H. G. J., & Wijdicks, E. F. M. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00036-1 · Cited by 33 · see citing works

Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity

McWhinney-Glass, S., Winham, S. J., Hertz, D. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0774 · Cited by 32 · see citing works

Neuropathies associated with lymphoma†

Grisold, W., Grisold, A., Marosi, C., et al. (2015) · Neuro-Oncology Practice · doi:10.1093/nop/npv025 · Cited by 32 · see citing works

GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients

Bergmann, T. K., Vach, W., Feddersen, S., Eckhoff, L., Gréen, H., Herrstedt, J., & Brøsen, K. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.707787 · Cited by 28 · see citing works

A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment

Mauermann, M. L., Blumenreich, M. S., Dispenzieri, A. A., et al. (2012) · Muscle & Nerve · doi:10.1002/mus.23493 · Cited by 27 · see citing works

The administration of chemotherapy in a patient with Charcot–Marie–Tooth and ovarian cancer

Martino, M. A., Miller, E., & Grendys, E. C. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.01.017 · Cited by 26 · see citing works

Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc©) in patients with chemotherapy‐induced peripheral neuropathy

Binda, D., Cavaletti, G., Cornblath, D. R., et al. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12140 · Cited by 25 · see citing works

Trying to unravel the mysteries of chemobrain

Holmes, D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70087-5 · Cited by 23 · see citing works

Lymphoma-associated dysimmune polyneuropathies

Stübgen, J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.003 · Cited by 22 · see citing works

Lenalidomide in patients with chemotherapy‐induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single‐centre prospective study

Briani, C., Torre, C. D., Campagnolo, M., Lucchetta, M., Berno, T., Candiotto, L., Padua, L., Ermani, M., Cavaletti, G., & Zambello, R. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12002 · Cited by 21 · see citing works

Neurologic complications of bone marrow transplantation

Rodriguez, T. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00088-2 · Cited by 19 · see citing works

Weekly Paclitaxel-Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma

Vandenput, I., Vergote, I. B., Neven, P., et al. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31824a3385 · Cited by 17 · see citing works

Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy

Azoulay, D., Leibovici, A., Sharoni, R., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3546-5 · Cited by 15 · see citing works

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer

Lorenzo, G. D., Bracarda, S., Gasparro, D., et al. (2016) · Medicine · doi:10.1097/md.0000000000002299 · Cited by 15 · see citing works

Neurologic complications of bone marrow and stem-cell transplantation in patients with cancer

Mathew, R. M., & Rosenfeld, M. R. (2007) · Current Treatment Options in Neurology · doi:10.1007/s11940-007-0016-3 · Cited by 14 · see citing works

Genesis of the structural pathology of myelinated fibers in median nerve entrapment

Ochoa, J. L. (2012) · Muscle & Nerve · doi:10.1002/mus.23458 · Cited by 14 · see citing works

Neurological complications in plasma cell dyscrasias

Bayat, E., & Kelly, J. J. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53502-3.00020-3 · Cited by 9 · see citing works

Raynaud′s phenomenon in a child with medulloblastoma as a late effect of chemotherapy

Ataş, E., Korkmazer, N., Artik, H. A., et al. (2015) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.144649 · Cited by 6 · see citing works

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., Donati, D., Kevric, M., Brosjö, O., Comandone, A., et al. (2018) · Tumori Journal · doi:10.5301/tj.5000696 · Cited by 123 · see citing works

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time

Wang, M., Cheng, H. L., Lopez, V., Sundar, R., Yorke, J., & Molassiotis, A. (2019) · BMC Cancer · doi:10.1186/s12885-019-6352-3 · Cited by 42 · see citing works

Lipid Nanoparticle Delivery of Chemically Modified NGF ^R100W mRNA Alleviates Peripheral Neuropathy

Yu, X., Yang, Z., Zhang, Y., Xia, J., Zhang, J., Han, Q., Yu, H., Wu, C., Xu, Y., Xu, W., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202127 · Cited by 38 · see citing works

The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review

Morimoto, T., Hirata, H., Watanabe, K., Kato, K., Otani, K., Mawatari, M., & Nikaido, T. (2024) · Cureus · doi:10.7759/cureus.55772 · Cited by 3 · see citing works

Effectiveness of the Traditional Japanese Medicine Goshajinkigan in Preventing Paclitaxel-Induced Peripheral Neuropathy: A Multicenter Randomized Comparative Trial

Matsumura, Y., Futagami, M., Baba, T., et al. (2024) · Integrative Cancer Therapies · doi:10.1177/15347354241278635 · Cited by 10 · see citing works

Response to: ‘Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study’

Kako, J., Kajiwara, K., Kobayashi, M., et al. (2019) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2019-001976

The Effects of Exercise on Symptoms of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Systematic Review and Meta-Analysis

Khmethong, U., Hawsawi, S., & Schneider, J. K. (2024) · Oncology nursing forum · doi:10.1188/24.onf.426-444 · Cited by 3 · see citing works

[Chemotherapy-induced peripheral neuropathy; impact on quality of life].

Scheel, A., Beijers, A. J. M., Mols, F., et al. (2014) · Research portal (Tilburg University) · Cited by 2 · see citing works

Chemotherapy-Induced Peripheral Neuropathy and Treatment

Ermiş, O., & Akçalı, D. T. (2023) · Journal of Anesthesiology and Reanimation Specialists’ Society · doi:10.54875/jarss.2023.06977